La eleccin del rea se personaliza segn las necesidades del paciente, asegurando resultados que se alineen con sus deseos
Phase 2 results (48 weeks): 1mg dose: 8.7% average weight loss 4mg dose: 17.1% average weight loss 8mg dose: 22.8% average weight loss 12mg dose: 24.2% average weight loss Placebo: 2.1% average weight loss These numbers came from a 48-week study period, six months shorter than the 72-week SURMOUNT trials
And just as a reminder, the content in this podcast episode is no substitute for medical advice, diagnosis, or treatment from your medical or licensed health care team
We accept OEM orders, just contact us and send us your request
Clugston, S
None of them addresses the actual claim being sold to biohackers, health conscious individuals or athletes which is that BPC-157 enhances recovery, repair, or longevity in healthy people